← Evidence map

ArticleCancer research2024

LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

Shu Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39088701